Compare QXO & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QXO | HOLX |
|---|---|---|
| Founded | 1988 | 1985 |
| Country | United States | United States |
| Employees | 7794 | N/A |
| Industry | EDP Services | Medical Electronics |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3B | 16.9B |
| IPO Year | N/A | 1995 |
| Metric | QXO | HOLX |
|---|---|---|
| Price | $17.84 | $76.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 13 |
| Target Price | $32.85 | ★ $77.89 |
| AVG Volume (30 Days) | 16.7M | ★ 95.4M |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | ★ $4,100,500,000.00 |
| Revenue This Year | $70.27 | $4.74 |
| Revenue Next Year | $38.75 | $5.03 |
| P/E Ratio | ★ N/A | $96.23 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $15.27 | $53.62 |
| 52 Week High | $27.61 | $76.07 |
| Indicator | QXO | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 35.37 | 69.09 |
| Support Level | $15.75 | $75.10 |
| Resistance Level | $19.68 | N/A |
| Average True Range (ATR) | 0.97 | 0.19 |
| MACD | -0.29 | 0.03 |
| Stochastic Oscillator | 0.45 | 95.19 |
QXO Inc is a publicly traded distributor of building products in North America. The company is executing its plan to become the tech-enabled leader in the around $800 billion building products distribution industry and generate outsized value for its shareholders. The group expects to achieve its target of nearly $50 billion in annual revenues within the next decade through accretive acquisitions and organic growth.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.